Neurosense Therapeutics Ltd (NRSN) Stock Analysis

Neurosense Therapeutics Ltd (NRSN) is a publicly traded company in the HEALTHCARE sector. It trades at $0.80, carries a market capitalization of $30.68M. This page summarizes the public market data, fundamentals, and frequently asked questions for NRSN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.80
• Market Cap: $30.68M
• EPS: $-0.44
• 52-Week High: $2.60
• 52-Week Low: $0.63

Market Sentiment

Neurosense Therapeutics Ltd currently has a Bullish sentiment score of 0.18.

About Neurosense Therapeutics Ltd

None

GNG Research Analysis

GNG Research scores Neurosense Therapeutics Ltd (NRSN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NRSN.

Frequently Asked Questions

Does NRSN pay dividends?

Neurosense Therapeutics Ltd (NRSN) does not currently pay a regular dividend.

What is NRSN's market cap?

Neurosense Therapeutics Ltd (NRSN) has a market capitalization of $30.68M with a current stock price of $0.80.